Cwm LLC Sells 2,134 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cwm LLC cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,259 shares of the pharmacy operator’s stock after selling 2,134 shares during the quarter. Cwm LLC’s holdings in Walgreens Boots Alliance were worth $816,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Exchange Traded Concepts LLC purchased a new stake in Walgreens Boots Alliance in the third quarter worth about $398,000. Asset Management One Co. Ltd. lifted its holdings in shares of Walgreens Boots Alliance by 1.5% during the third quarter. Asset Management One Co. Ltd. now owns 515,429 shares of the pharmacy operator’s stock valued at $11,463,000 after purchasing an additional 7,470 shares during the last quarter. Brookstone Capital Management lifted its holdings in shares of Walgreens Boots Alliance by 37.8% during the third quarter. Brookstone Capital Management now owns 588,152 shares of the pharmacy operator’s stock valued at $12,328,000 after purchasing an additional 161,252 shares during the last quarter. Commonwealth Equity Services LLC lifted its holdings in shares of Walgreens Boots Alliance by 5.7% during the third quarter. Commonwealth Equity Services LLC now owns 905,638 shares of the pharmacy operator’s stock valued at $20,141,000 after purchasing an additional 49,097 shares during the last quarter. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in shares of Walgreens Boots Alliance by 4.2% during the third quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 240,564 shares of the pharmacy operator’s stock valued at $5,350,000 after purchasing an additional 9,700 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. HSBC reiterated a “reduce” rating and set a $20.00 target price (down from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Finally, Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a report on Monday, April 1st. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $24.36.

Insider Activity at Walgreens Boots Alliance

In related news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $18.02 on Tuesday. Walgreens Boots Alliance, Inc. has a 1 year low of $17.49 and a 1 year high of $35.36. The firm has a fifty day moving average price of $19.93 and a 200-day moving average price of $21.72. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same quarter in the previous year, the firm posted $1.16 EPS. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.55%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.29%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.